<DOC>
	<DOCNO>NCT01461434</DOCNO>
	<brief_summary>Atrial fibrillation ( AF ) common clinical arrhythmia . AF associate increase risk stroke due blood clot form fibrillate atrium . Some patient characteristic increase likelyhood AF time risk stroke AF develop . To reduce risk stroke , anticoagulation therapy recommend patient AF risk factor ( high blood pressure , diabetes , vessel disease ) . However , occasional ( paroxysmal ) AF may occur without symptom remain undetected , leave patient risk . Aim prospective randomize study compare two management strategy patient increase risk AF without know history AF . Patients see regularly ( monthly , quarterly ) follow-up ( incl . ECG record blood sample ) . One group patient additionally receive subcutaneous implantation loop recorder continuous rhythm monitoring , control group remain standard follow-up . Observation period one year ( optional extension 3 year ) . The time first diagnosis AF compare group , blood sample analyze potential biomarkers AF .</brief_summary>
	<brief_title>Graz Study Risk Atrial Fibrillation</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Vascular Diseases</mesh_term>
	<criteria>CHA2DS2VASc risk score &gt; = 4* 18 year old know history atrial fibrillation implant rhythm device preexist indication oral anticoagulation ( * ) CHA2DS2VASc : C chronic heart failure ( 1 point ) ; H hypertension ( 1 point ) ; A age &gt; = 75 year ( 2 point ) ; D diabetes ( 1 point ) ; S stroke ( 2 point ) ; V vascular disease ( 1 point ) ; A age &gt; =65 &lt; 75 year ( 1 point ) ; Sc sex category ( female ) ( 1 point ) ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>atrial fibrillation</keyword>
	<keyword>biomarkers</keyword>
	<keyword>stroke prevention</keyword>
	<keyword>implantable loop recorder</keyword>
</DOC>